BLOOD CANCERS
Clinical trials for BLOOD CANCERS explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCERS trials appear
Sign up with your email to follow new studies for BLOOD CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to wipe out lingering leukemia cells before they return
Disease control Recruiting nowThis study tests whether a new combination of three drugs (tagraxofusp, azacitidine, and venetoclax) can safely eliminate leftover leukemia cells that are not visible under a microscope in adults with acute myeloid leukemia (AML). These hidden cells can cause the cancer to come b…
Matched conditions: BLOOD CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New tool aims to ensure blood cancer patients get the care they truly want
Knowledge-focused Recruiting nowThis study tests a decision-support tool called PRIME for adults aged 60 and older with blood cancers like lymphoma, leukemia, or multiple myeloma. The tool helps patients clarify their personal values and shares that information with their doctors. The goal is to see if using PR…
Matched conditions: BLOOD CANCERS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC